BioTime Inc.

BioTime Inc.
Stock Exchange NYSE
EPS
$0.44
Market Cap
$141.17 M
Shares Outstanding
149.64 M
Public Float
125.51 M
BioTime Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
126.88 M
Public Float
88.71 M

Profile

Address
1010 Atlantic Avenue
Alameda California 94501
United States
Employees -
Website http://www.biotimeinc.com
Updated 07/08/2019
BioTime, Inc. is a clinical-stage biotechnology company, which deals with degenerative diseases. The company's programs are based on two core proprietary technology platforms: cell replacement and cell and drug delivery. Its cell replacement platform creates new cells and tissues with its pluripotent and progenitor cell technologies.

Financials

View All
Created with Highcharts 5.0.14BioTime Inc.Net Income. Fiscal year is January-December. All values USD Thousands.43 88243 88236 41136 41146 99146 99133 57233 57219 97619 97645 99045 990201320142015201620172018010k20k30k40k50k
Created with Highcharts 5.0.14BioTime Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.4 4344 4345 2435 2437 0367 0365 9235 9233 4583 4581 4161 41620132014201520162017201802k4k6k8k

Alfred Dennis Kingsley
Chairman
Aditya P. Mohanty
President, Co-Chief Executive Officer & Director